# Phase 1 Single Dose Escalation Study of CTB-001

> **NCT01647893** · PHASE1 · UNKNOWN · sponsor: **HLB Pharmaceutical Co., Ltd.** · enrollment: 33 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CTB-001

## Key facts

- **NCT ID:** NCT01647893
- **Lead sponsor:** HLB Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2012-11
- **Final completion:** 2012-12
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2012-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01647893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01647893, "Phase 1 Single Dose Escalation Study of CTB-001". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01647893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*